What does Highlight Capital invest in?
Highlight Capital invests most often at Series B and Venture (54% of the rounds on record), in sectors such as Healthcare and Technology.
China · Investor
Last cheque observed May 2026; 78 cheques on record.
Deploying nowNew fund $904K, Nov 2022VC firmWebsite unconfirmed
Follow Highlight Capital and see its new cheques in your feed.Start following
Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. Tell us which if you know.
11 cheques in the last 12 months
Mostly Series B and Venture: 54% of its rounds
Sole investor in 23 rounds, median $14M
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
Every round we can evidence, newest first78 appearances
8 rounds
25 rounds
7 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
We also hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
The investors most often in the same rounds as Highlight Capital. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Highlight Capital put money into.
Highlight Capital invests most often at Series B and Venture (54% of the rounds on record), in sectors such as Healthcare and Technology.
78 investments on record, 11 of them in the last 12 months. The most recent was in May 2026.
Its most recent investments on record: Vivatides Therapeutics (Series A, May 2026), Nuclidium (Series B, May 2026) and ImageneBio (Undisclosed round, Apr 2026).
The median round it joins is $25M.
Rarely, if at all: none of its 78 investments on record names it as the lead.
Most of the companies it backs are in the United States (36%), Switzerland (27%) and China (9%).
Yes: it is actively investing, with 11 investments in the last 12 months.
Most often Qiming Venture Partners (7 rounds together), CICC (5 rounds together) and Shunwei Capital (5 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it